Roche Diagnostics China (wanda ake kira "Roche") da kuma Beijing Hotgene Biotechnology Co., Ltd. (wanda ake kira "Hotgene") sun cimma haɗin gwiwa don ƙaddamar da sabon sabon coronavirus (2019-nCoV) kayan gano antigenic akan na'urar. tushe na cikakken haɗakar fa'idodin fasaha da albarkatun ɓangarorin biyu, don biyan bukatun jama'a don gano antigenic a ƙarƙashin sabon yanayin.
Maganganun bincike masu inganci sune tushe da jigon binciken Roche na ƙirƙira da haɗin kai na gida.Kit ɗin gwajin antigen na COVID-19 da aka ƙaddamar tare da haɗin gwiwar Hotgene ya wuce tabbataccen aikin samfur, kuma an shigar da shi tare da NMPA kuma an sami takardar shaidar rajistar na'urar likita.Hakanan an jera ta a cikin jerin masana'antun kayan gwajin antigen guda 49 da aka amince da su akan rajistar kasa, suna ba da cikakken garantin ingancin gwajin, don taimakawa jama'a daidai da sauri gano kamuwa da cutar COVID-19.
An ba da rahoton cewa wannan kayan gano antigen ɗin yana ɗaukar hanyar sanwici na rigakafin mutum biyu, wanda ya dace da gano in vitro qualitative gano sabon coronavirus (2019 nCoV) N antigen a cikin samfuran swab na hanci.Masu amfani za su iya tattara samfurori da kansu don kammala samfurin.Ganowar antigen yana da fa'idodi na ƙarfin hana tsangwama mai ƙarfi akan magungunan toshewa gama gari, haɓakar ganowa, daidaito da ɗan gajeren lokacin ganowa.A lokaci guda kuma, kit ɗin yana ɗaukar ƙirar jaka daban, wanda ya dace don ɗauka kuma ana iya amfani da shi kuma a gwada shi nan da nan.
Dangane da sabbin sauye-sauyen rigakafin kamuwa da cuta na yanzu, da kuma takamaiman amfani da kayan gano antigen da yawan jama'a, wannan na'urar gano antigen ta COVID-19 tana ɗaukar yanayin tallace-tallace na kan layi don haɓaka damar sa.Dogaro da dandamalin tallace-tallacen kan layi na Roche – Shagon Kan layi na Tmall”, masu amfani za su iya samun wannan kayan gwajin cikin sauri da dacewa don cimma nasarar kula da lafiyar kai na gida.
Lokacin aikawa: Janairu-09-2023
